Biodegradation, biodistribution and toxicity of chitosan

Advanced Drug Delivery Reviews

Volumn 62, Issue 1, 2010, Pages 3-11

  Kean, T ^a   Thanou, M ^b  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Biodegradation; Biodistribution; Chitosan; Delivery; In vitro; In vivo; Toxicity

Indexed keywords

BASIC PROPERTIES; BIODISTRIBUTION; BIODISTRIBUTIONS; BIOLOGICAL PROPERTIES; BIOTECH COMPANY; CHEMICAL ENTITY; COMPATIBLE MATERIALS; IN-VITRO; IN-VIVO; LARGE GROUPS; NATURAL POLYSACCHARIDE;

BIODEGRADATION; CHITIN; CHITOSAN; DEGRADATION; DRUG DELIVERY; MICROBIOLOGY; TISSUE ENGINEERING; TOXICITY;

HYDROGELS;

CHITIN; CHITINASE; CHITOSAN; CHITOSAN DERIVATIVE; CHITOTRIOSIDASE; DOXORUBICIN; FLUORESCEIN ISOTHIOCYANATE; HOLMIUM; IODINE 125; MITOMYCIN; NANOPARTICLE; PACLITAXEL; TECHNETIUM 99M;

BIOACCUMULATION; BIODEGRADATION; CELLULAR DISTRIBUTION; CHEMICAL MODIFICATION; CLINICAL TRIAL; CRYSTAL STRUCTURE; CYTOTOXICITY; DEACETYLATION; DRUG ABSORPTION; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG SAFETY; ENZYME ACTIVITY; ENZYME DEGRADATION; ENZYME SUBSTRATE COMPLEX; FOOD AND DRUG ADMINISTRATION; HUMAN; IC 50; IN VITRO STUDY; IN VIVO STUDY; LD 50; LIVER CELL CARCINOMA; MOLECULAR WEIGHT; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; RADIOACTIVITY; REVIEW; TISSUE DISTRIBUTION; URINARY EXCRETION;

ANIMALS; BIOTRANSFORMATION; CHITOSAN; DRUG DELIVERY SYSTEMS; HUMANS; TISSUE DISTRIBUTION;

EID: 75149147526     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.addr.2009.09.004     Document Type: Review

References (97)

1. Onishi H., and Machida Y. Biodegradation and distribution of water-soluble chitosan in mice. Biomaterials 20 (1999) 175-182
2. Tommeraas K., Strand S.P., Tian W., Kenne L., and Varum K.M. Preparation and characterisation of fluorescent chitosans using 9-anthraldehyde as fluorophore. Carbohydr. Res. 336 (2001) 291-296
3. Hejazi R., and Amiji M. Stomach-specific anti-h. Pylori therapy. I: preparation and characterization of tetracyline-loaded chitosan microspheres. Int. J. Pharm. 235 (2002) 87-94
4. Richardson S.C., Kolbe H.V., and Duncan R. Potential of low molecular mass chitosan as a DNA delivery system: biocompatibility, body distribution and ability to complex and protect DNA. Int. J. Pharm. 178 (1999) 231-243
5. Banerjee T., Mitra S., Kumar Singh A., Kumar Sharma R., and Maitra A. Preparation, characterization and biodistribution of ultrafine chitosan nanoparticles. Int. J. Pharm. 243 (2002) 93-105
6. Soane R.J., Frier M., Perkins A.C., Jones N.S., Davis S.S., and Illum L. Evaluation of the clearance characteristics of bioadhesive systems in humans. Int. J. Pharm. 178 (1999) 55-65
7. Hsu S.-C., Don T.-M., and Chiu W.-Y. Free radical degradation of chitosan with potassium persulfate. Polym. Degrad. Stab. 75 (2002) 73-83
8. Zoldners J., Kiseleva T., and Kaiminsh I. Influence of ascorbic acid on the stability of chitosan solutions. Carbohydr. Polym. 60 (2005) 215-218
9. KEGG Pathway, Amino sugar and nucleotide sugar metabolism. 2009, Kanehisa Laboratories.
10. T. Kean, M. Thanou, Chitin and chitosan-sources, production and medical applications, in: P.A. Williams, R. Arshady (Eds.), Desk reference of Natural Polymers, their Sources, Chemistry and Applications, Kentus Books, London, 2009, pp. 327-361.
11. Funkhouser J.D., and Aronson Jr. N.N. Chitinase family gh18: evolutionary insights from the genomic history of a diverse protein family. BMC Evol. Biol. 7 (2007) 96
12. Huet J., Rucktooa P., Clantin B., Azarkan M., Looze Y., Villeret V., and Wintjens R. X-ray structure of papaya chitinase reveals the substrate binding mode of glycosyl hydrolase family 19 chitinases. Biochemistry 47 (2008) 8283-8291
13. Collinge D.B., Kragh K.M., Mikkelsen J.D., Nielsen K.K., Rasmussen U., and Vad K. Plant chitinases. Plant J. 3 (1993) 31-40
14. Kasprzewska A. Plant chitinases-regulation and function. Cell Mol. Biol. Lett. 8 (2003) 809-824
15. Yang Y.M., Hu W., Wang X.D., and Gu X.S. The controlling biodegradation of chitosan fibers by n-acetylation in vitro and in vivo. J. Mater. Sci. Mater. Med. 18 (2007) 2117-2121
16. Xu J., McCarthy S.P., Gross R.A., and Kaplan D.L. Chitosan film acylation and effects on biodegradability. Macromolecules 29 (1996) 3436-3440
17. Correa J.U., Elango N., Polacheck I., and Cabib E. Endochitinase, a mannan-associated enzyme from Saccharomyces cerevisiae. J. Biol. Chem. 257 (1982) 1392-1397
18. Molinari L.M., Pedroso R.B., Scoaris Dde O., Ueda-Nakamura T., Nakamura C.V., and Dias Filho B.P. Identification and partial characterisation of a chitinase from Nile tilapia, Oreochromis niloticus. Comp. Biochem. Physiol. B Biochem. Mol. Biol. 146 (2007) 81-87
19. Boot R.G., Blommaart E.F., Swart E., Ghauharali-van der Vlugt K., Bijl N., Moe C., Place A., and Aerts J.M. Identification of a novel acidic mammalian chitinase distinct from chitotriosidase. J. Biol. Chem. 276 (2001) 6770-6778
20. Hartl D., He C.H., Koller B., Da Silva C.A., Homer R., Lee C.G., and Elias J.A. Acidic mammalian chitinase is secreted via an adam17/epidermal growth factor receptor-dependent pathway and stimulates chemokine production by pulmonary epithelial cells. J. Biol. Chem. 283 (2008) 33472-33482
21. Zhu Z., Zheng T., Homer R.J., Kim Y.K., Chen N.Y., Cohn L., Hamid Q., and Elias J.A. Acidic mammalian chitinase in asthmatic th2 inflammation and il-13 pathway activation. Science 304 (2004) 1678-1682
22. Stirling J.L. Nn′-diacetylchitobiase activity in Tay-Sachs disease and Sandhoff's disease. Biochem. J. 141 (1974) 597-599
23. Kuranda M.J., and Aronson Jr. N.N. A di-n-acetylchitobiase activity is involved in the lysosomal catabolism of asparagine-linked glycoproteins in rat liver. J. Biol. Chem. 261 (1986) 5803-5809
24. Hollak C.E., van Weely S., van Oers M.H., and Aerts J.M. Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease. J. Clin. Invest. 93 (1994) 1288-1292
25. Renkema G.H., Boot R.G., Muijsers A.O., Donker-Koopman W.E., and Aerts J.M. Purification and characterization of human chitotriosidase, a novel member of the chitinase family of proteins. J. Biol. Chem. 270 (1995) 2198-2202
26. Malaguarnera L. Chitotriosidase: the yin and yang. Cell. Mol. Life Sci. 63 (2006) 3018-3029
27. Senel S., and McClure S.J. Potential applications of chitosan in veterinary medicine. Adv. Drug Deliv. Rev. 56 (2004) 1467-1480
28. Zhang H., and Neau S.H. In vitro degradation of chitosan by bacterial enzymes from rat cecal and colonic contents. Biomaterials 23 (2002) 2761-2766
29. Lu G., Sheng B., Wang G., Wei Y., Gong Y., Zhang X., and Zhang L. Controlling the degradation of covalently cross-linked carboxymethyl chitosan utilizing bimodal molecular weight distribution. J. Biomater. Appl. 23 (2009) 435-451
30. Kafedjiiski K., Foger F., Hoyer H., Bernkop-Schnurch A., and Werle M. Evaluation of in vitro enzymatic degradation of various thiomers and cross-linked thiomers. Drug Dev. Ind. Pharm. 33 (2007) 199-208
31. Rao S.B., and Sharma C.P. Use of chitosan as a biomaterial: studies on its safety and hemostatic potential. J. Biomed. Mater. Res. 34 (1997) 21-28
32. Kittur F.S., Vishu Kumar A.B., and Tharanathan R.N. Low molecular weight chitosans-preparation by depolymerization with Aspergillus niger pectinase, and characterization. Carbohydr. Res. 338 (2003) 1283-1290
33. Kittur F.S., Vishu Kumar A.B., Varadaraj M.C., and Tharanathan R.N. Chitooligosaccharides-preparation with the aid of pectinase isozyme from Aspergillus niger and their antibacterial activity. Carbohydr. Res. 340 (2005) 1239-1245
34. McConnell E.L., Murdan S., and Basit A.W. An investigation into the digestion of chitosan (noncrosslinked and crosslinked) by human colonic bacteria. J. Pharm. Sci. 97 (2008) 3820-3829
35. Verheul R.J., Amidi M., van Steenbergen M.J., van Riet E., Jiskoot W., and Hennink W.E. Influence of the degree of acetylation on the enzymatic degradation and in vitro biological properties of trimethylated chitosans. Biomaterials 30 (2009) 3129-3135
36. Ma L., Gao C., Mao Z., Zhou J., Shen J., Hu X., and Han C. Collagen/chitosan porous scaffolds with improved biostability for skin tissue engineering. Biomaterials 24 (2003) 4833-4841
37. Ishihara M., Obara K., Ishizuka T., Fujita M., Sato M., Masuoka K., Saito Y., Yura H., Matsui T., Hattori H., Kikuchi M., and Kurita A. Controlled release of fibroblast growth factors and heparin from photocrosslinked chitosan hydrogels and subsequent effect on in vivo vascularization. J. Biomed. Mater. Res. A. 64 (2003) 551-559
38. Langoth N., Kahlbacher H., Schoffmann G., Schmerold I., Schuh M., Franz S., Kurka P., and Bernkop-Schnurch A. Thiolated chitosans: design and in vivo evaluation of a mucoadhesive buccal peptide drug delivery system. Pharm. Res. 23 (2006) 573-579
39. Hirano S., Seino H., Akiyama Y., and Nonaka I. Bio-compatibility of chitosan by oral and intravenous administrations. Proceedings of the ACS Division of Polymeric Materials: Science and Engineering, American Chemical Society (1988), Los Angeles, California
40. Kato Y., Onishi H., and Machida Y. Evaluation of n-succinyl-chitosan as a systemic long-circulating polymer. Biomaterials 21 (2000) 1579-1585
41. Suzuki Y.S., Momose Y., Higashi N., Shigematsu A., Park K.B., Kim Y.M., Kim J.R., and Ryu J.M. Biodistribution and kinetics of holmium-166-chitosan complex (dw-166hc) in rats and mice. J. Nucl. Med. 39 (1998) 2161-2166
42. Banerjee T., Singh A.K., Sharma R.K., and Maitra A.N. Labeling efficiency and biodistribution of technetium-99m labeled nanoparticles: interference by colloidal tin oxide particles. Int. J. Pharm. 289 (2005) 189-195
43. Zhang C., Qu G., Sun Y., Wu X., Yao Z., Guo Q., Ding Q., Yuan S., Shen Z., Ping Q., and Zhou H. Pharmacokinetics, biodistribution, efficacy and safety of n-octyl-o-sulfate chitosan micelles loaded with paclitaxel. Biomaterials 29 (2008) 1233-1241
44. Alexis F., Pridgen E., Molnar L.K., and Farokhzad O.C. Factors affecting the clearance and biodistribution of polymeric nanoparticles. Mol. Pharmacol. 5 (2008) 505-515
45. Gupta A.K., and Gupta M. Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials 26 (2005) 3995-4021
46. Line B.R., Weber P.B., Lukasiewicz R., and Dansereau R.N. Reduction of background activity through radiolabeling of antifibrin fab′ with 99mtc-dextran. J. Nucl. Med. 41 (2000) 1264-1270
47. Zhang C., Qu G., Sun Y., Yang T., Yao Z., Shen W., Shen Z., Ding Q., Zhou H., and Ping Q. Biological evaluation of n-octyl-o-sulfate chitosan as a new nano-carrier of intravenous drugs. Eur. J. Pharm. Sci. 33 (2008) 415-423
48. Kato Y., Onishi H., and Machida Y. Biological fate of highly-succinylated n-succinyl-chitosan and antitumor characteristics of its water-soluble conjugate with mitomycin c at i.v. And i.p. administration into tumor-bearing mice. Biol. Pharm. Bull. 23 (2000) 1497-1503
49. Kumar R.M.N.V. A review of chitin and chitosan applications. React. Funct. Polym. 46 (2000) 1-27
50. Xu G., Huang X., Qiu L., Wu J., and Hu Y. Mechanism study of chitosan on lipid metabolism in hyperlipidemic rats. Asia Pac. J. Clin. Nutr. 16 (2007) 313-317
51. Chae S.Y., Jang M.K., and Nah J.W. Influence of molecular weight on oral absorption of water soluble chitosans. J. Control. Release 102 (2005) 383-394
52. Zheng F., Shi X.W., Yang G.F., Gong L.L., Yuan H.Y., Cui Y.J., Wang Y., Du Y.M., and Li Y. Chitosan nanoparticle as gene therapy vector via gastrointestinal mucosa administration: results of an in vitro and in vivo study. Life Sci. 80 (2007) 388-396
53. Ishii T., Okahata Y., and Sato T. Mechanism of cell transfection with plasmid/chitosan complexes. Biochim. Biophys. Acta 1514 (2001) 51-64
54. Leong K.W., Mao H.Q., Truong-Le V.L., Roy K., Walsh S.M., and August J.T. DNA-polycation nanospheres as non-viral gene delivery vehicles. J. Control. Release 53 (1998) 183-193
55. Park I.K., Kim T.H., Kim S.I., Park Y.H., Kim W.J., Akaike T., and Cho C.S. Visualization of transfection of hepatocytes by galactosylated chitosan-graft-poly(ethylene glycol)/DNA complexes by confocal laser scanning microscopy. Int. J. Pharm. 257 (2003) 103-110
56. Janes K.A., Fresneau M.P., Marazuela A., Fabra A., and Alonso M.J. Chitosan nanoparticles as delivery systems for doxorubicin. J. Control. Release 73 (2001) 255-267
57. Nam H.Y., Kwon S.M., Chung H., Lee S.Y., Kwon S.H., Jeon H., Kim Y., Park J.H., Kim J., Her S., Oh Y.K., Kwon I.C., Kim K., and Jeong S.Y. Cellular uptake mechanism and intracellular fate of hydrophobically modified glycol chitosan nanoparticles. J. Control. Release 135 (2009) 259-267
58. Dodane V., and Vilivalam V.D. Pharmaceutical applications of chitosan. Pharm. Sci. Technol. Today 1 (1998) 246-253
59. Thanou M., Verhoef J.C., and Junginger H.E. Oral drug absorption enhancement by chitosan and its derivatives. Adv. Drug Delivery Rev. 52 (2001) 117-126
60. Illum L. Chitosan and its use as a pharmaceutical excipient. Pharm. Res. 15 (1998) 1326-1331
61. Wedmore I., McManus J.G., Pusateri A.E., and Holcomb J.B. A special report on the chitosan-based hemostatic dressing: experience in current combat operations. J. Trauma 60 (2006) 655-658
62. Carreño-Gómez B., and Duncan R. Evaluation of the biological properties of soluble chitosan and chitosan microspheres. Int. J. Pharm. 148 (1997) 231-240
63. Sgouras D. The evaluation of biocompatibility of soluble polymers and assessment of their potential as specific drug delivery systems, in Pharmacy (1990), Keele, University of Keele
64. Wan K.W., Malgesini B., Verpilio I., Ferruti P., Griffiths P.C., Paul A., Hann A.C., and Duncan R. Poly(amidoamine) salt form: effect on ph-dependent membrane activity and polymer conformation in solution. Biomacromolecules 5 (2004) 1102-1109
65. Schipper N.G., Varum K.M., and Artursson P. Chitosans as absorption enhancers for poorly absorbable drugs. 1: influence of molecular weight and degree of acetylation on drug transport across human intestinal epithelial (caco-2) cells. Pharm. Res. 13 (1996) 1686-1692
66. Schipper N.G., Varum K.M., Stenberg P., Ocklind G., Lennernas H., and Artursson P. Chitosans as absorption enhancers of poorly absorbable drugs. 3: influence of mucus on absorption enhancement. Eur. J. Pharm. Sci. 8 (1999) 335-343
67. Thanou M.M., Verhoef J.C., Romeijn S.G., Nagelkerke J.F., Merkus F.W., and Junginger H.E. Effects of n-trimethyl chitosan chloride, a novel absorption enhancer, on caco-2 intestinal epithelia and the ciliary beat frequency of chicken embryo trachea. Int. J. Pharm. 185 (1999) 73-82
68. Kean T., Roth S., and Thanou M. Trimethylated chitosans as non-viral gene delivery vectors: cytotoxicity and transfection efficiency. J. Control. Release 103 (2005) 643-653
69. Baruch L., and Machluf M. Alginate-chitosan complex coacervation for cell encapsulation: effect on mechanical properties and on long-term viability. Biopolymers 82 (2006) 570-579
70. Jumaa M., Furkert F.H., and Muller B.W. A new lipid emulsion formulation with high antimicrobial efficacy using chitosan. Eur. J. Pharm. Biopharm. 53 (2002) 115-123
71. Guo Z., Chen R., Xing R., Liu S., Yu H., Wang P., Li C., and Li P. Novel derivatives of chitosan and their antifungal activities in vitro. Carbohydr. Res. 341 (2006) 351-354
72. Pujals G., Sune-Negre J.M., Perez P., Garcia E., Portus M., Tico J.R., Minarro M., and Carrio J. In vitro evaluation of the effectiveness and cytotoxicity of meglumine antimoniate microspheres produced by spray drying against Leishmania infantum. Parasitol. Res. 102 (2008) 1243-1247
73. Hirano S., Iwata M., Yamanaka K., Tanaka H., Toda T., and Inui H. Enhancement of serum lysozyme activity by injecting a mixture of chitosan oligosaccharides intravenously in rabbits. Agric. Biol. Chem. 55 (1991) 2623-2625
74. Song Y., Onishi H., and Nagai T. Conjugate of mitomycin c with n-succinyl-chitosan: in vitro drug release properties, toxicity and antitumor activity. Int. J. Pharm. 98 (1993) 121-130
75. Ono K., Saito Y., Yura H., Ishikawa K., Kurita A., Akaike T., and Ishihara M. Photocrosslinkable chitosan as a biological adhesive. J. Biomed. Mater. Res. 49 (2000) 289-295
76. Azad A.K., Sermsintham N., Chandrkrachang S., and Stevens W.F. Chitosan membrane as a wound-healing dressing: characterization and clinical application. J. Biomed. Mater. Res. B Appl. Biomater. 69 (2004) 216-222
77. Ishihara M., Ono K., Sato M., Nakanishi K., Saito Y., Yura H., Matsui T., Hattori H., Fujita M., Kikuchi M., and Kurita A. Acceleration of wound contraction and healing with a photocrosslinkable chitosan hydrogel. Wound Repair Regen. 9 (2001) 513-521
78. Kim J.K., Han K.H., Lee J.T., Paik Y.H., Ahn S.H., Lee J.D., Lee K.S., Chon C.Y., and Moon Y.M. Long-term clinical outcome of phase iib clinical trial of percutaneous injection with holmium-166/chitosan complex (milican) for the treatment of small hepatocellular carcinoma. Clin. Cancer Res. 12 (2006) 543-548
79. Gades M.D., and Stern J.S. Chitosan supplementation and fecal fat excretion in men. Obes. Res. 11 (2003) 683-688
80. Arai K., Kinumaki T., and Fujita T. Toxicity of chitosan. Bull. Tokai Reg. Fish. Res. Lab. 56 (1968) 89-94
81. Sonaje K., Lin Y.H., Juang J.H., Wey S.P., Chen C.T., and Sung H.W. In vivo evaluation of safety and efficacy of self-assembled nanoparticles for oral insulin delivery. Biomaterials 30 (2009) 2329-2339
82. Illum L., Farraj N.F., and Davis S.S. Chitosan as a novel nasal delivery system for peptide drugs. Pharm. Res. 11 (1994) 1186-1189
83. FDA. Alphabetical listing of gras notices. 2009 [cited May 14th 2009]; Available from: http://www.cfsan.fda.gov/~rdb/opagras1.html.
84. Brenner B.M., Hostetter T.H., and Humes H.D. Glomerular permselectivity: barrier function based on discrimination of molecular size and charge. Am. J. Physiol. 234 (1978) F455-F460
85. Miyauchi K., Tsubuku N., Matsumiya M., and Mochizuki A. Characterization of lysozymes from three shellfish. Fish. Sci. 73 (2007) 1404-1406
86. Garcia-Alonso J., Reglero A., and Cabezas J.A. Purification and properties of beta-n-acetylhexosaminidase a from pig brain. Int. J. Biochem. 22 (1990) 645-651
87. Sanon A., Tournaire-Arellano C., El Hage S.Y., Bories C., Caujolle R., and Loiseau P.M. N-acetyl-beta-d-hexosaminidase from Trichomonas vaginalis: substrate specificity and activity of inhibitors. Biomed. Pharmacother. 59 (2005) 245-248
88. Akeboshi H., Chiba Y., Kasahara Y., Takashiba M., Takaoka Y., Ohsawa M., Tajima Y., Kawashima I., Tsuji D., Itoh K., Sakuraba H., and Jigami Y. Production of recombinant beta-hexosaminidase a, a potential enzyme for replacement therapy for Tay-Sachs and Sandhoff diseases, in the methylotrophic yeast Ogataea minuta. Appl. Environ. Microbiol. 73 (2007) 4805-4812
89. Fu J.Y., Wu S.M., Chang C.T., and Sung H.Y. Characterization of three chitosanase isozymes isolated from a commercial crude porcine pepsin preparation. J. Agric. Food Chem. 51 (2003) 1042-1048
90. Andronopoulou E., and Vorgias C.E. Purification and characterization of a new hyperthermostable, allosamidin-insensitive and denaturation-resistant chitinase from the hyperthermophilic archaeon thermococcus chitonophagus. Extremophiles 7 (2003) 43-53
91. Watanabe T., Kanai R., Kawase T., Tanabe T., Mitsutomi M., Sakuda S., and Miyashita K. Family 19 chitinases of streptomyces species: characterization and distribution. Microbiology 145 (1999) 3353-3363
92. Wiwat C., Siwayaprahm P., and Bhumiratana A. Purification and characterization of chitinase from Bacillus circulans no.4.1. Curr. Microbiol. 39 (1999) 134-140
93. Martinou A., Koutsioulis D., and Bouriotis V. Expression, purification, and characterization of a cobalt-activated chitin deacetylase (cda2p) from Saccharomyces cerevisiae. Protein Expr. Purif. 24 (2002) 111-116
94. Ye Y.Q., Chen F.Y., Wu Q.A., Hu F.Q., Du Y.Z., Yuan H., and Yu H.Y. Enhanced cytotoxicity of core modified chitosan based polymeric micelles for doxorubicin delivery. J. Pharm. Sci. 98 (2009) 704-712
95. Opanasopit P., Aumklad P., Kowapradit J., Ngawhiranpat T., Apirakaramwong A., Rojanarata T., and Puttipipatkhachorn S. Effect of salt forms and molecular weight of chitosans on in vitro permeability enhancement in intestinal epithelial cells (caco-2). Pharm. Dev. Technol. 12 (2007) 447-455
96. Mao S., Shuai X., Unger F., Wittmar M., Xie X., and Kissel T. Synthesis, characterization and cytotoxicity of poly(ethylene glycol)-graft-trimethyl chitosan block copolymers. Biomaterials 26 (2005) 6343-6356
97. Murata J.-i., Ohya Y., and Ouchi T. Design of quaternary chitosan conjugate having antennary galactose residues as a gene delivery tool. Carbohydr. Polym. 32 (1997) 105-109